The prognostic value of dynamic contrast-enhanced MRI contrast agent transfer constant K(trans) in cervical cancer is explained by plasma flow rather than vessel permeability.
Authors
Dickie, Ben RRose, C
Kershaw, Lucy E
Withey, S
Carrington, Bernadette M
Davidson, Susan E
Hutchison, G
West, Catharine M L
Affiliation
Division of Molecular and Clinical Cancer Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester M20 4BX, UKIssue Date
2017-04-27
Metadata
Show full item recordAbstract
The microvascular contrast agent transfer constant K(trans) has shown prognostic value in cervical cancer patients treated with chemoradiotherapy. This study aims to determine whether this is explained by the contribution to K(trans) of plasma flow (Fp), vessel permeability surface-area product (PS), or a combination of both.Citation
The prognostic value of dynamic contrast-enhanced MRI contrast agent transfer constant K(trans) in cervical cancer is explained by plasma flow rather than vessel permeability. 2017 Br J CancerJournal
British Journal of CancerDOI
10.1038/bjc.2017.121PubMed ID
28449009Type
ArticleLanguage
enISSN
1532-1827ae974a485f413a2113503eed53cd6c53
10.1038/bjc.2017.121
Scopus Count
Collections
Related articles
- Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
- Authors: Lee CC, Chen CW, Yen HK, Lin YP, Lai CY, Wang JL, Groot OQ, Janssen SJ, Schwab JH, Hsu FM, Lin WH
- Issue date: 2024 Dec 1
- Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
- Authors: Bryant A, Hiu S, Kunonga PT, Gajjar K, Craig D, Vale L, Winter-Roach BA, Elattar A, Naik R
- Issue date: 2022 Sep 26
- Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
- Authors: Elwenspoek MM, Thom H, Sheppard AL, Keeney E, O'Donnell R, Jackson J, Roadevin C, Dawson S, Lane D, Stubbs J, Everitt H, Watson JC, Hay AD, Gillett P, Robins G, Jones HE, Mallett S, Whiting PF
- Issue date: 2022 Oct
- Are we making progress in curing advanced cervical cancer-again?
- Authors: Lindegaard JC, Petric P, Tan LT, Hoskin P, Schmid MP, Jürgenliemk-Schulz I, Mahantshetty U, Kirisits C, Pötter R
- Issue date: 2024 Dec 2
- RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
- Authors: Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Tissot Dupont H, Honoré S, Colson P, Chabrière E, La Scola B, Rolain JM, Brouqui P, Raoult D
- Issue date: 2020 Jul